Skip to main content


9 result(s) for 'author#Peter M Ndumbe' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. Achieving the Millennium Development Goals (MDGs) and combating hotspots with escalating but preventable communicable diseases remain major challenges in Africa. The European and Developing Countries Clinical ...

    Authors: George M Miiro, Odile Ouwe Missi Oukem-Boyer, Ousmane Sarr, Maerangis Rahmani, Francine Ntoumi, Keertan Dheda, Alexander Pym, Souleymane Mboup and Pontiano Kaleebu
    Citation: BMC Public Health 2013 13:258
  2. European and Developing Countries Clinical Trials Partnership (EDCTP) was founded in 2003 by the European Parliament and Council. It is a partnership of 14 European Union (EU) member states, Norway, Switzerlan...

    Authors: Mecky I Matee, Christine Manyando, Peter M Ndumbe, Tumani Corrah, Walter G Jaoko, Andrew Y Kitua, Herman PA Ambene, Mathieu Ndounga, Lynn Zijenah, David Ofori-Adjei, Simon Agwale, Steven Shongwe, Thomas Nyirenda and Michael Makanga
    Citation: BMC Public Health 2009 9:249
  3. Though documented that HIV infection progresses with the depletion of CD4+ cells, the exact mechanisms by which these cell depletions occur are not clearly understood. This study aimed at evaluating the plasma...

    Authors: George M Ikomey, Marie-Claire Okomo-Assoumou, Julius Atashili, Martha T Mesembe, Bertha Mukwele, Emilia Lyonga, Agnes Eyoh and Peter M Ndumbe
    Citation: BMC Research Notes 2012 5:322
  4. Cameroon is one of 12 African countries that bear most of the global burden of yellow fever. In 2002 the country developed a five-year strategic plan for yellow fever control, which included strategies for pre...

    Authors: Charles Shey Wiysonge, Emmanuel Nomo, Jeanne Mawo, James Ofal, Julienne Mimbouga, Johnson Ticha and Peter M Ndumbe
    Citation: BMC Medicine 2008 6:3
  5. In this study we assess the prevalence, characteristics as well as socio-demographic and clinical correlates of a positive screen for HIV-associated dementia in a group of patients on antiretroviral therapy (A...

    Authors: Julius Atashili, Bradley N Gaynes, Brian W Pence, Gladys Tayong, Dmitry Kats, Julie K O’donnell, Peter M Ndumbe and Alfred K Njamnshi
    Citation: BMC Neurology 2013 13:86
  6. Cervical squamous intra-epithelial lesions (SIL) are more frequent in HIV-positive women overall. However the appropriate age at which to begin and end cervical cancer screening for early detection of lesions ...

    Authors: Julius Atashili, William C Miller, Jennifer S Smith, Peter M Ndumbe, George M Ikomey, Joseph Eron, Allen C Rinas, Evan Myers and Adaora A Adimora
    Citation: BMC Research Notes 2012 5:590
  7. The implementation of strategic immunization plans whose development is informed by available locally-relevant research evidence should improve immunization coverage and prevent disease, disability and death i...

    Authors: Charles S Wiysonge, Olalekan A Uthman, Peter M Ndumbe and Gregory D Hussey
    Citation: BMC Medicine 2013 11:66
  8. Rapid scale-up of antiretroviral therapy (ART) and limited access to genotyping assays in low-resource settings (LRS) are inevitably accompanied by an increasing risk of HIV drug resistance (HIVDR). The curren...

    Authors: Joseph Fokam, Serge C Billong, Bissek Anne C ZK, Etienne Kembou, Pascal Milenge, Ibile Abessouguie, Armand S Nkwescheu, Zephirin Tsomo, Avelin F Aghokeng, Grace D Ngute, Peter M Ndumbe, Vittorio Colizzi and Jean BN Elat
    Citation: BMC Public Health 2013 13:308